Akademisyen profili · PROFESÖR
BURHAN TURGUT
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
20
Q2
30
Q3
25
Q4
2
WoS (JCR)
Q1
8
Q2
15
Q3
23
Q4
36
TR Index
16
makale
Makaleler
- 2025 The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer
- 2024 Brentuximab Vedotin Monotherapy in Relapsed/Refractory T Cell Lymphoma Setting-Real Life Data
- 2024 Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey
- 2023 A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera
- 2022 Yüksek Riskli Diffüz Büyük B Hücreli Lenfoma Olgularında DA-EPOCH-R Deneyimi
- 2022 Measurable Residual Disease in Chronic Lymphocytic Leukemia: Experience in Real-Life Setting with Dry Tube Flow Cytometric Method
- 2010 Pap smear screening among the postmenopausal women
- 2024 Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma
- 2023 Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores
- 2023 Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations
- 2023 Acquired Hemophilia A In Adults: A Multicenter Study from Turkey.
- 2023 International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report
- 2023 Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
- 2022 PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA
- 2022 The Real\u2010World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
- 2022 Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
- 2022 The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
- 2022 Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients
- 2022 Severe immune thrombocytopenia in pregnancy treated with eltrombopag. A case report.
- 2021 Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients